Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00940888 · ClinicalTrials.gov registry record
SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients
A clinical trial of Heart Failure and Sudden Cardiac Death, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,701
- Enrollment target
- 1
- Study location
NCT00940888: Completed study of Heart Failure and Sudden Cardiac Death, sponsored by Abbott Medical Devices.
NCT00940888 is a study of Heart Failure and Sudden Cardiac Death that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,701 participants, below the 2,045-participant average among 397 other Heart Failure trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00940888, a study of Heart Failure and Sudden Cardiac Death, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,701 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize the chronic performance of the St. Jude Medical SJ4 connector and RV high voltage SJ4 leads.
Conditions Studied
Interventions
- DEVICE SJ4 connector and RV high voltage SJ4 lead
Study Locations (1)
Ohio
- The Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,701 participants |
| Start Date | 2009-06 |
| Est. Completion | 2015-12 |
What the finished NCT00940888 record still lists
NCT00940888 is an observational study that tracks outcomes without assigning an intervention. Its 1,701 participants enrollment target places it among the larger protocols in the corpus, below the 2,045-participant average among 397 other Heart Failure trials with a reported enrollment target (17% lower).
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which SJ4 connector and RV high voltage SJ4 lead is the first listed.
NCT00940888 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00940888 about?
NCT00940888 is a clinical study titled "SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients". The purpose of this study is to characterize the chronic performance of the St. Jude Medical SJ4 connector and RV high voltage SJ4 leads.
What is the current status of trial NCT00940888?
This trial is currently completed. The enrollment target is 1,701 participants. The study started on 2009-06. Estimated completion is 2015-12.
What conditions does trial NCT00940888 study?
This clinical trial studies the following conditions: Heart Failure, Sudden Cardiac Death, Tachyarrhythmias.
What interventions are being tested in trial NCT00940888?
The interventions under investigation include: SJ4 connector and RV high voltage SJ4 lead (DEVICE).
Who is sponsoring clinical trial NCT00940888?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00940888 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00940888's enrollment target sits among peer trials
1,701 50th of 397 higher than 348 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- NCT07284901 · 1,700 participants · Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia